Innovative Health Initiative (IHI)

Innovative Health Initiative (IHI) is dedicated to translating health research and innovation into tangible benefits for patients and society, ensuring Europe remains at the forefront of interdisciplinary and patient-centric health research. Located in Brussels, IHI fosters collaboration across diverse sectors to promote a more integrated approach to healthcare, encompassing prevention, diagnosis, treatment, and disease management. The primary address is Brussels, - 1049, BE.

As a pioneering public-private partnership, Innovative Health Initiative drives health research and innovation through strategic funding and effective management of projects. By uniting the European Union with leading industry associations, including COCIR, EFPIA (and Vaccines Europe), EuropaBio, and MedTech Europe, IHI leverages a substantial budget to support groundbreaking initiatives. These initiatives aim to address critical healthcare challenges and enhance the quality of life for individuals across Europe and beyond.

Innovative Health Initiative (IHI) builds upon the accomplishments of its predecessor, the Innovative Medicines Initiative (IMI), continuing to manage and promote projects launched under IMI. Through its commitment to excellence and collaboration, IHI is shaping the future of healthcare research and innovation. We invite the management of Innovative Health Initiative to create a customized and exclusive company showcase and product listing on our platform to further amplify their impact and reach.